Abstract
The similarities and differences between normal tissue stem cells and cancer stem cells (CSCs) have been the source of much contention, with some recent studies calling into question the very existence of CSCs. An examination of the literature indicates, however, that the CSC model rests on firm experimental foundations and that differences in the observed frequencies of CSCs within tumors reflect the various cancer types and hosts used to assay these cells. Studies of stem cells and the differentiation program termed the epithelial-mesenchymal transition (EMT) point to the possible existence of plasticity between stem cells and their more differentiated derivatives. If present, such plasticity would have major implications for the CSC model and for future therapeutic approaches.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
British Journal of Cancer Open Access 09 February 2023
-
TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
BMC Cancer Open Access 06 December 2022
-
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma
BMC Cancer Open Access 19 October 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Kelly, P.N., Dakic, A., Adams, J.M., Nutt, S.L. & Strasser, A. Science 317, 337 (2007).
Quintana, E. et al. Nature 456, 593–598 (2008).
Clarke, M.F. et al. Cancer Res. 66, 9339–9344 (2006).
Lapidot, T. et al. Nature 367, 645–648 (1994).
Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Proc. Natl. Acad. Sci. USA 100, 3983–3988 (2003).
Singh, S.K. et al. Cancer Res. 63, 5821–5828 (2003).
Bonnet, D. & Dick, J.E. Nat. Med. 3, 730–737 (1997).
Harris, M.A. et al. Cancer Res. 68, 10051–10059 (2008).
Thon, N. et al. Mol. Cell Neurosci. published online, doi: 10.1016/j.mcn.2008.07.022 (7 August 2008).
Chiou, S.H. et al. Clin. Cancer Res. 14, 4085–4095 (2008).
Honeth, G. et al. Breast Cancer Res. 10, R53 (2008).
Kennedy, J.A., Barabe, F., Poeppl, A.G., Wang, J.C. & Dick, J.E. Science 318, 1722 (2007).
Zhang, M. et al. Cancer Res. 68, 4674–4682 (2008).
Cho, R.W. et al. Stem Cells 26, 364–371 (2008).
Deshpande, A.J. et al. Cancer Cell 10, 363–374 (2006).
Wu, A. et al. Stem Cells Dev. 17, 173–184 (2008).
Mani, S.A. et al. Cell 133, 704–715 (2008).
Morel, A.P. et al. PLoS One 3, e2888 (2008).
Thiery, J.P. Curr. Opin. Cell Biol. 15, 740–746 (2003).
Hugo, H. et al. J. Cell. Physiol. 213, 374–383 (2007).
Brabletz, T. et al. Proc. Natl. Acad. Sci. USA 98, 10356–10361 (2001).
Yook, J.I. et al. Nat. Cell Biol. 8, 1398–1406 (2006).
Till, J.E., McCulloch, E.A. & Siminovitch, L. Proc. Natl. Acad. Sci. USA 51, 29–36 (1964).
Santisteban, M. et al. Cancer Res. 69, 2887–2895 (2009).
Clarkson, B. & Strife, A. Leuk. Lymphoma 11, 101–107 (1993).
Barr, S. et al. Clin. Exp. Metastasis 25, 685–693 (2008).
Buck, E. et al. Cancer Res. 68, 8322–8332 (2008).
Li, X. et al. J. Natl. Cancer Inst. 100, 672–679 (2008).
Thomson, S. et al. Cancer Res. 65, 9455–9462 (2005).
Woodward, W.A. et al. Proc. Natl. Acad. Sci. USA 104, 618–623 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, P., Chaffer, C. & Weinberg, R. Cancer stem cells: mirage or reality?. Nat Med 15, 1010–1012 (2009). https://doi.org/10.1038/nm0909-1010
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0909-1010
This article is cited by
-
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
British Journal of Cancer (2023)
-
Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer
Journal of Translational Medicine (2022)
-
Glioblastoma CD105+ cells define a SOX2− cancer stem cell-like subpopulation in the pre-invasive niche
Acta Neuropathologica Communications (2022)
-
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Journal of Hematology & Oncology (2022)
-
TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
BMC Cancer (2022)